Cost-effectiveness of cell-based influenza vaccine in France
Introducing cell-based influenza vaccines in the French immunization program prevents influenza cases, hospitalizations, death, while reducing costs versus egg-based influenza vaccines.
Authors
- Emanuele Ciglia
- G. Gavazzi (ORCID: https://orcid.org/0000-0001-8375-7153)
- Henri Leleu (ORCID: https://orcid.org/0000-0003-4930-6767)
- Joaquin Mould-Quevedo (ORCID: https://orcid.org/0000-0003-4847-5956)
- Nansa Burlet (ORCID: https://orcid.org/0000-0001-8539-0789)
- Quentin Berkovitch
- Romain Moreau
- Marc Paccalin
Institutions
- Centre Hospitalier Universitaire de Grenoble (FR)
- Centre Hospitalier Universitaire de Poitiers (FR)
- Seqirus (United States) (US)
- Vifor Pharma (United States) (US)
Publication Details
- Journal
- Expert Review of Vaccines
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1080/14760584.2024.2417854
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39